Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US00507K1034
Ticker AGN
Company ALLERGAN
Currency $
Price
Aware Investor Index (AII) 0.0001
Recommendation STRONG SELL
P/E 59.14
ROE 1.11 %
Capitalization 42,667,570,000 $
Dividend Yield 0.00 %
P/S 2.70
AII Position 701
P/E Position 612
ROE Position 719
Capitalization Position 216
Dividend Yield Position 594
Sales 15,787,400,000 $
10-Year Average Earnings 721,520,000 $
Shares Outstanding 337,000,000
Equity 65,131,000,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country United States
ALLERGAN Investor Relations Web Site http://www.allergan.com/INVESTORS







Sales:

YEAR MONTH AMOUNT
2018 12 15,787,400,000.00 $
2017 12 15,940,700,000.00 $
2016 12 14,570,600,000.00 $
2015 12 15,071,000,000.00 $
2014 12 13,062,300,000.00 $
2013 12 8,677,600,000.00 $
2012 12 5,914,900,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 -5,142,800,000.00 $
2017 12 -4,403,900,000.00 $
2016 12 14,695,000,000.00 $
2015 12 3,683,200,000.00 $
2014 12 -1,630,500,000.00 $
2013 12 -750,400,000.00 $
2012 12 97,300,000.00 $
2011 12 260,900,000.00 $
2010 12 184,400,000.00 $
2009 12 222,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 65,131,000,000.00 $
2017 12 73,837,100,000.00 $
2016 12 76,200,500,000.00 $
2015 12 76,589,300,000.00 $
2014 12 28,335,500,000.00 $
2013 12 9,537,100,000.00 $
2012 12 3,856,400,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 337,000,000
2017 12 333,800,000
2016 12 384,900,000
2015 12 367,800,000
2014 12 219,700,000
2013 12 142,300,000
2012 12 128,400,000

 









Comments:

DATE COMMENT
2014-04-19 13:06:45 Equity increased after Warner Chilcott acquisition



Bloomberg News for ALLERGAN:



Google News for ALLERGAN:

The News Heater - 2 hours ago
Is a Correction Looming Ahead? Allergan plc (AGN)
Allergan plc (NYSE:AGN) went down by -0.16% from its latest closing price when compared to the 1-year high value of $197.00 and move ...
NewsSmooth (press release)
Allergan plc's (NYSE:AGN) Profit Outlook
Allergan plc's (NYSE:AGN): Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, ...
Wagner Review
Allergan (AGN) Down 9.7% Since Last Earnings Report: Can It ...
It has been about a month since the last earnings report for Allergan (AGN). Shares have lost about 9.7% in that time frame, underperforming ...
Auburn Digest
Is Allergan plc (AGN) A Good Stock To Buy ?
Allergan plc (NYSE:AGN) was in 53 hedge funds' portfolios at the end of the first quarter of 2019. AGN shareholders have witnessed a ...
Yahoo Finance - 3 days ago
Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti
Amgen, Inc. AMGN and its biosimilar collaboration partner, Allergan AGN announced that the FDA has approved Kanjinti (trastuzumab-anns), ...
Wagner Review
Catabasis Pharmaceuticals (NASDAQ:CATB) and Allergan ...
Catabasis Pharmaceuticals (NASDAQ:CATB) and Allergan (NYSE:AGN) are both medical companies, but which is the superior investment?
Rockland Register
Short Sellers Are Making Bigger Bets Against Teva and Allergan Stock
Two of the largest jumps in short interest were in Allergan PLC (ticker: AGN) and Teva Pharmaceutical Industries (TEVA), both driven by ...
Tyndall Times
Span A Noted Below Span B for Allergan Plc (AGN)
Tracking the levels for Allergan Plc (AGN), we have seen that after a recent glance, Span A is currently lower than Span B. This indicator ...
Yahoo Finance - 6 Jun 2019
Northwestern Mutual Wealth Management Co. Has $2.56 Million ...
Northwestern Mutual Wealth Management Co. increased its stake in Allergan plc (NYSE:AGN) by 10.3% during the 1st quarter, according to its ...
Yahoo Finance - 10 Jun 2019
Allergan's (AGN) Vraylar Gets FDA Nod for Bipolar Depression
Allergan plc AGN along with Hungary's Gedeon Richter Plc announced that the FDA has approved a supplemental new drug application ...


Back